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• Antibiotic susceptibility of bacterial cultures were rapidly analysed by TD-GC-MS  
 
• Cultures were analysed in under 30 minutes vs. 24 hours for traditional tests  
 
• Differences in volatile profiles found between resistant and sensitive bacteria  
 




Antibiotic resistance is set to be an unprecedented threat to modern medicine. ‘Sniffing’ 
bacteria potentially offers a rapid way to determine susceptibility. A successful proof-of-
principle study is described, using thermal desorption-gas chromatography-mass 
spectrometry (TD-GC-MS) to ‘smell’ cephalexin and ciprofloxacin resistant and sensitive 
Urinary Tract Infection (UTI)-causing bacteria. 578 peaks at unique retention times were 
detected from 86 chromatograms of 18 bacterial isolates (E. coli, K. pneumoniae and P. 
aeruginosa). The isolates were grown with and without the presence of antibiotic. Chi-square 
analysis found 9 compounds that differed significantly between cephalexin sensitive and 
resistant isolates, and 22 compounds that differed significantly between ciprofloxacin sensitive 
and resistant isolates, at p ≤0.05. When antibiotic was added to the media, more differences 
were found in the cephalexin group, attributed to lysis, but not in the ciprofloxacin group. 
Further work with large sample sizes will potentially enable the development of diagnostic 
algorithms using presence/absence of particular compounds of interest.  
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1. Introduction  
 
There is a need for more rapid determination of antibiotic resistance (ABR) in bacteria isolated 
from clinical samples. ABR is becoming more prevalent, as are urinary tract infections (UTIs) 
due to an aging population. The WHO states up to 8 million urinary-tract infections occur in 
the United States each year, and each year, a growing and significant proportion – hard to 
measure, but probably 1 in 10, or 800,000 – are antibiotic-resistant [1]. Rapid diagnosis and 
appropriate treatment will decrease morbidity and healthcare costs.  
 
The aim of any rapid diagnostic is to confirm infection and then susceptibility. Species 
identification is not always necessary, but can allow predictions about susceptibility in the 
absence of any other test, and might help suggest source of infection, or likely prognosis. 
Current time to confirm culture positivity, bacterial identification and susceptibility is 48-72 
hours from urine [3], and 72 hours from blood [4] depending on starting culture density 
(susceptibility testing from culture takes 24 hours).  
 
The WHO stated that the lengthy turnaround time for microbiological testing means 
practitioners often forgo it and prescribe broad-spectrum antibiotics [2]. Inappropriate 
prescribing of antibiotics in human and veterinary medicine is arguably the biggest driver of 
resistance, and is potentially avoidable. However, rapid bacterial identification direct from 
clinical samples, and more importantly, rapid antibiotic susceptibility testing is essential to 
make significant impact on inappropriate antibiotic prescribing.  
 
Certain resistance mechanisms (e.g. production of enzymes/efflux pumps/altered binding 
sites) may use valuable energy and resources, and in the absence of a selection pressure, 
bacteria may stop expressing these resistance mechanisms. Therefore, the metabolism of a 
bacterium conferring resistance should be different from its sensitive counterpart, and these 
changes may be detectable using gas chromatography-mass spectrometry (GC-MS) to 
measure volatile metabolites.  
 
Bacteria produce a wide and diverse range of volatile compounds. These compounds may be 
produced as by-products of metabolism, but they can also act as signalling molecules for 
communication between bacteria, or between bacteria and host. Although these interactions 
aren’t fully understood, they are thought to play an important role in antibiotic resistance, as 
described in a review by Schmidt et al. (2015) [5].  
 
Much research has been conducted into analysing the volatile compound (VC) profiles of 
common infectious bacteria [6]; and the aim has often been differentiation between species. 
For example, McGuire et al. (2014) rapidly differentiated C. difficile from other diarrhoea 
causing aetiologies using a custom-made GC-sensor system featuring a short multi-capillary 
column [7] and Shestivska et al. (2015) found in vitro data indicating methylbutanol isomers 
may be exhaled breath biomarkers of S. maltophilia lung infection in patients with cystic 
fibrosis [8].  
 
UTIs are most frequently caused by Escherichia coli, as well other enteric bacterial pathogens 
such as Enterococci, Klebsiella, Staphylococci, and Proteus species, and fungal pathogen 
such as Candida albicans [9]. The first review on the potential applications of VOCs for 
identifying such UTIs was in 2001 by Guernion et al. [10]. Since then, there have been various 
reports showing that this approach has been promising, for instance as described in the review 
by Capelli et al. (2016) on electronic nose technology [11], and Storer et al. (2011) using 
selected ion flow tube-mass spectrometry [12]. More recently, Rees et al. (2018) used gas 
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chromatography mass spectrometry to identify pathogen-specific volatile metabolite profiles 
for 10 organisms responsible for 90% of urine and bloodstream infections [13]. It remains the 
case that more analytical work is needed on VOC profiling of urine headspace, in terms of 
sensitivity and reproducibility, so that research results can be transformed into routine clinic 
use.  
 
Few groups have looked at differences between antibiotic resistant and sensitive strains. Zhu 
et al. (2013) showed methicillin-resistant Staphylococcus aureus (MRSA) can be detected in 
lung infections in mice via breath analysis [14]. Boots et al. (2014) found differences in the 
VCs produced by methicillin resistant and sensitive Staphylococcus aureus using a similar 
methodology as employed in this investigation [15], showing that GC-MS can be used 
effectively for this purpose. Most notably the compounds 1,1,2,2-tetrachloroethane, 2-
heptanone and 1,4-dichlorobenzene showed significant differences. Weisner et al. (2014) 
used ion/molecule reaction-MS to analyse bacterial VCs, to differentiate the susceptibility of 
E. coli and S. aureus to ampicillin and oxacillin. They identified methanethiol as a marker for 
bacterial growth, however, only one sensitive and one resistant isolate of each species was 
studied. The authors then investigated the use of a metal oxide sensor to detect this 
compound, with promising initial results [16].  
 
There is still a lack of published literature on rapid identification of antibiotic resistant bacteria 
relevant to UTIs using volatile profiling. This proof of principle paper explores the potential of 
volatiles to address this, by determining the volatile markers involved using GC-MS, it could 
lead to low-cost vapour detection technologies at point of care.  
 
2. Experimental section  
 
18 bacterial isolates (from University of Bristol School of Cellular and Molecular Medicine) 
were studied, which included three UTI-causing bacterial species with focus on the 
commonest aetiological agent (E. coli). Details are in table 1.  
Table 1. Bacterial isolates showing number of repeats (n) with and without the addition of 
antibiotics  
E. coli 














17 1  2, 3, 0 K30  3, 0, 0 PA01 13  2, 0, 0 
IR10  3, 3, 3 R1  2, 0, 3 301-5473 218  3, 0, 0 
IR60  3, 3, 3 R2  3, 0, 3 - - 
PSA 1  3, 3, 0 NLTC505514  2, 0, 0 - - 
RKV 29  3, 3, 0 -  - - - 
VCE 17  3, 2, 0 - - - - 
CDG  2, 0, 0 - - - - 
DH5α  
(PYT vector)  
4, 2, 0 - - - - 
DH5α  
(PYT vector + 
CTXM)  
4, 2, 0 - - - - 
DH5α  
(PYT vector + 
NDM1)  
3, 2, 0 - - - - 
17  
(PSU18 vector 
+ CTXM)  
0, 3, 0 - - - - 
17  
(PSU18 vector 
+ NDM1)  
0, 3, 0 - - - - 
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Overnight cultures were set up by using 10ml of nutrient broth in 10ml universal containers 
(Oxoid), inoculated with a 10 μl loop of frozen glycerinated stock culture, and then grown in a 
shaking incubator at 180 rpm and 37°C). The overnight cultures were then sub-cultured into 
10 ml headspace vials with silicone rubber PTFE septa (Sigma-Aldrich), (60 µl inoculated into 
3 ml of Muller-Hinton broth (Oxoid)) and grown for three hours as before. The optical densities 
of the cultures were between 0.7 and 1.1 at 600 nm (exponential growth phase). In some 
cases, cephalexin or ciprofloxacin antibiotics (both Sigma-Aldrich) were added to the media 
after 2.5 hours. Kanamycin was added to all cultures of DH5α (PYT vector) for plasmid 
retention. A media control of Muller-Hinton broth, incubated for three hours at 180 rpm and 
37°C, was also analysed by GC-MS.  
Susceptibility to cephalexin and ciprofloxacin was determined for each of the isolates by 
performing disc diffusion tests on Mueller-Hinton agar (Oxoid) at minimum inhibitory 
concentrations. The isolates were assigned sensitive, intermediate or resistant to cephalexin 
and ciprofloxacin, based on the measurements of the zones of inhibition. Intermediate isolates 
were not included for analysis of that antibiotic.  
 
2.2. Analytical techniques  
 
Volatile metabolites in the vial headspace were loaded onto stainless steel TD tubes with 
appropriate adsorbents (TENAX TA 68 mg for C6 to C30 compounds and Sulficarb 26 mg for 
C3 to C8 compounds (Markes International Ltd)), by pumping purified room temperature lab. 
air (pumped through an Activated Charcoal Purifier (Alltech®) containing 4-12 mesh activated 
charcoal (DARCO®)) at 80 ml/min for two minutes using a custom-built tube loading rig, as 
described in Gould et al. (2018) [17]. Tubes were analysed the following day if possible, or 
stored at -80°C and analysed within three weeks. Tubes were analysed on a TD-GC-MS 
system (Unity model 1 TD with Ultra 2 auto-sampler (Markes International ltd.), 6890N-GC 
5973N-MS GC-MS system (Agilent)). Volatiles were separated using an RTx-624SilMS 
column (60 m x 0.32 mm x 1.8 μm (Restek)).  
The TD-GC-MS method was taken from a recommended application by Agilent Technologies 
Inc. for the analysis of VCs [18]. Detailed parameters are in table 2.  
Table 2. TD-GC-MS parameters 
Parameters Setting 
GC  
Carrier gas Helium in a constant pressure mode 
Initial oven temperature 45°C 
Temperature ramp(s) Ramped by 10°C per minute to 190°C, then 
further ramped by 20°C per minute to 250°C 
MS  
Mode Scan mode 
Scan range and rate 33-300 m/z (8 scans per peak) 
Source temperature 230°C 
Quadrupole temperature 150°C 
Transfer line temperature 260°C 
TD  
Pre-purge time 1.0 minutes 
Primary desorb 200°C for 10 minutes 
Trap desorb 250°C for 5 minutes (Trap heating rate 100°C/s) 
Trap (low temperature) -7°C 
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Trap type General purpose hydrophobic (C4/5-C26) 
(tenax/graphitised carbon black) 
Flow path temperature 140°C 
Nominal carrier gas pressure 30.9 psi 
Desorb flow 20 ml/min 
 
2.3. Data analysis  
 
Data files were initially converted to .CDF files using Agilent Chemstation® software. 
Chromatograms were opened using Perkin-Elmer Turbomass software and peak areas 
calculated. Peak areas with a total ion current (TIC) of less than 10,000 were not included in 
the data analysis. Compounds were identified using the NIST 2014 library.  
 
Background subtraction was undertaken manually for each of the peaks, to reduce 
background “noise” and spectral overlap due to partial co-elution of compounds. NIST’s 
suggested general guidelines were taken into account for assignations; match factor scores 
>900 are considered an excellent match, 800- 900 as a good match, 700-800 as a fair match, 
and <600 as a poor match [19]. Many of the compounds had an excellent match, compounds 
that had a reverse fit NIST library score <800 were not assigned a chemical identity and were 
assigned a unique number, starting with the shortest retention time. These were referred to 
as ‘unknowns’. Siloxane-containing compounds and suspected plasticisers were not included 
in data analysis, as these do not have a biological origin or may be attributed to breakdown of 
the GC column or septa.  
 
Retention time matching of 7 compounds (acetaldehyde, 2-butanone, dimethyl disulphide, 
decane, 2-ethyl-1-hexanol, decanal and indole) was undertaken. The compounds were 
selected as they are readily commercially available; all compounds were supplied by Sigma-
Aldrich. A standard mix of the compounds dissolved in methanol was directly injected onto the 
TD tubes used previously (1 μl injections), and analysed using the GC-MS method as before, 
in duplicate. The chromatograms were analysed using Turbomass software and compounds 
were identified using the NIST library and matched on retention time (within 1% or 6 seconds 
of the retention time, whichever is greater) [20].  
 
Statistical differences were assessed with chi-square tests, using presence and absence of 
compounds (absence = peak area <10,000 TIC). Statistical analysis taking into account 
relative differences in the amount of each compound, using peak area as a measure of 
abundance, was also performed for each compound with independent samples T-tests and 
Mann-Whitney-Wilcoxon tests.  
 
3. Results and discussion  
 
578 peaks at unique retention times were detected above the threshold peak area from 86 





































Figure 1. A typical chromatogram of a P. aeruginosa isolate (top) and of an E. coli isolate (bottom)  
 
A media control was analysed, and 21 peaks were identified above the threshold of 10,000 
TIC. Since all bacteria were grown in Mueller-Hinton broth, differences in compounds also 
present in the media can be attributed to bacteria either depleting or producing the compounds 
at different rates.  
 
Statistical analysis using chi-square tests found 31 compounds whose presence/absence 
differed significantly between species (E. coli, K. pneumoniae and P. aeruginosa) at p ≤0.05, 
shown in table 3 and figure S1 in supplementary material.  
 
Table 3. Compounds which are different in E. coli (EC), K. pneumoniae (KP) or 
















absent in PA 
(than in EC or 
KP) 
More likely 
present in KP 
(than in PA or 
EC) 
More likely 
absent in EC 
(than in PA or 
KP) 
Unknown 1 3.39 3.3 13.3 40.0 
More likely 
present in PA  
- More likely 
absent in EC 
Butane  3.72 6.7 20.0 0.0 
- More likely 
present in KP 
- 
Unknown 2 4.27 0.0 13.3 0.0 
- More likely 
present in KP 
More likely 
absent in EC 
Ethanol  5.56 0.0 0.0 60.0 
More likely 
present in PA  
- More likely 
absent in EC 
Acetone  6.29 0.0 0.0 40.0 
More likely 
present in PA  
- More likely 
absent in EC 
2-Butanone  9.33 6.7 6.7 60.0 
More likely 
present in PA  
- - 
3-Methylbutanal 10.83 0.0 13.3 0.0 
- More likely 
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Dimethyl 
disulphide 12.59 13.3 26.6 60.0 
More likely 
present in PA  
More likely 
present in KP 
More likely 
absent in EC 
3-Methyl-1-
butanol 12.64 0.0 13.3 0.0 
- More likely 
present in KP 
More likely 
absent in EC 
3-Methylbutyl 
acetate 14.55 0.0 20.0 0.0 
- More likely 
present in KP 
More likely 
absent in EC 
Unknown 3 14.68 0.0 0.0 20.0 
More likely 
present in PA  
- - 
α-Pinene 15.4 0.0 13.3 0.0 
- More likely 
present in KP 
More likely 
absent in EC 
Unknown 4 15.89 0.0 0.0 20.0 
More likely 
present in PA  
- - 
Trimethylbenzene 15.92 0.0 6.7 40.0 
More likely 
present in PA  
- More likely 
absent in EC 
Dimethyl 
trisulphide  16.31 13.3 13.3 60.0 
More likely 
present in PA  
- - 
4-Methylstyrene 16.53 0.0 6.7 20.0 
- - More likely 
absent in EC 
Octyl ether 16.69 3.3 0.0 20.0 
More likely 
present in PA  
- - 
2-Ethyl-1-hexanol 16.72 13.3 26.7 60.0 
- - More likely 
absent in EC 
Unknown 5 16.82 0.0 0.0 20.0 
More likely 
present in PA  
- - 
Unknown 6 16.91 0.0 0.0 20.0 
More likely 
present in PA  
- - 
Undecane  16.98 0.0 0.0 60.0 
More likely 
present in PA  
- More likely 
absent in EC 
2-Methyl-1-
hexadecanol 17.07 0.0 0.0 40.0 
More likely 
present in PA  
- More likely 
absent in EC 
Isopropyl 
benzene  17.69 26.7 6.7 0.0 
More likely 
absent in PA  
- More likely 
absent in EC 
Dodecane 18.25 3.3 0.0 40.0 
More likely 
present in PA  
- - 
Decanal 18.96 20.0 33.3 60.0 
- - More likely 
absent in EC 
Tridecane 19.61 0.0 0.0 60.0 
More likely 
present in PA  
- More likely 
absent in EC 
Cyclohexyl 
isothiocyanate 20.27 0.0 0.0 20.0 
More likely 
present in PA  
- - 
Benzothiazole 20.34 6.7 6.7 40.0 
More likely 
present in PA  
- - 
Pentadecane 23.35 0.0 6.7 40.0 
More likely 
present in PA  
- More likely 
absent in EC 
Unknown 7 23.62 0.0 0.0 40.0 
More likely 
present in PA  
- - 
Unknown 8 24.97 0.0 0.0 20.0 
More likely 
present in PA  
- - 
EC = E. coli, KP = K. pneumoniae and PA = P. aeruginosa. RT = retention time. Additional spectral 
information for unknowns presented in table S1 in supplementary information.  
 
These findings were compared to the literature, using the recently published microbial volatile 
database (mVOC 2.0) [21]. P. aeruginosa was shown to be much more likely to bio-synthesise 
organo-sulphides, particularly dimethyl disulphide and dimethyl trisulphide. Dimethyl 
disulphide has been found previously in this species [22] and benzothiazole, pentadecane and 
dodecane have been found in several Pseudomonas species [23]. Isopropyl benzene, which 
was more likely to be absent in P. aeruginosa (found in 0% of isolates) has also never been 
found previously in P. aeruginosa. Of the compounds more likely to be present in K. 
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pneumoniae, only 3-methylbutanal [24], and 3-methyl-1-butanol [25-26] have been found 
before. This study has potentially identified new VCs which are descriptive for these two 
species. It is worth noting that 3-methyl-1-butanol, 3-methylbutanal and 3-methylbutyl acetate 
are related; 3-methylbutanal can be readily produced by facile oxidation from 3-methyl-1-
butanol and esterification will produce the acetate. All 3 compounds were found in K. 
pneumoniae and not in E. coli or P. aeruginosa. For E. coli, of the compounds more likely to 
be absent, undecane, 2-methyl-1-hexadecanol, isopropyl benzene, 4-methylstyrene and 
decanal have also never been identified from this species before.  
 
Chi-square analysis identified 9 compounds whose presence/absence differed significantly 
between cephalexin sensitive and cephalexin resistant bacterial isolates at p ≤0.05, without 
cephalexin added to the media, shown in table 4. When cephalexin was added to the media 
containing bacterial isolates, 16 compounds were identified that differed significantly in terms 
of presence/absence at p = ≤0.05, shown in table 5.   
 
Table 4. Compounds which are different in cephalexin sensitive and resistant E. coli and K. 
pneumoniae isolates, and the percentage occurrence of compounds in samples  
 













Carbon dioxide 3.64 15.8 0.0 Unknown 1 3.39 0.0 19.2 
1-Dodecanol 24.03 15.8 0.0 Acetone 6.30 0.0 23.1 
- - - - 2-Butanone 9.33 0.0 23.1 
- - - - 4-Cyanocyclohexane 17.19 0.0 19.2 
- - - - Isopropyl benzene 17.69 0.0 19.2 
- - - - Benzothiazole 20.34 0.0 19.2 
- - - - 2,6-Bis(1,1-
dimethylethyl)-1,4-
benzenediol  
20.51 0.0 19.2 
S = sensitive and R = resistant. RT = retention time. Additional spectral information for unknowns 
presented in table S1 in supplementary information.   
 
Table 5. Compounds which are different in cephalexin sensitive and resistant E. coli isolates 
with antibiotic added to culture media, and the percentage occurrence of compounds in 
samples  
 













Ethanol 5.54 23.1 0.0 Dimethyl trisulphide 16.30 7.7 56.3 
Acetone 6.29/ 
6.30 
61.5 0.0 - - - - 
Dimethyl sulphide 6.51/ 
6.52 
61.5 0.0 - - - - 
Isopropyl alcohol 6.67 23.1 0.0 - - - - 
Methyl ethyl sulphide 9.30 61.5 0.0 - - - - 
Trichloromethane  9.88 46.2 0.0 - - - - 
Dimethyl disulphide 12.59-
12.70 
100 6.3 - - - - 
Decane 15.82 53.8 6.3 - - - - 
5-Hepten-2-one,  
6-methyl- 
16.17 23.1 0.0 - - - - 
Octanal 16.36/ 
16.37 
84.6 18.8 - - - - 
2-Ethyl-1-hexanol 16.71 53.8 12.5 - - - - 
1-Propenethiol 17.16 23.1 0.0 - - - - 
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Decanal 18.95 23.1 0.0 - - - - 
Undecanal 20.49 38.5 0.0 - - - - 
Dodecanal 22.42/ 
22.43 
76.9 6.3 - - - - 
S = sensitive and R = resistant. RT = retention time. AB = antibiotic (cephalexin).  
 
With the exception of acetone, the compounds found to be different in isolates grown without 
antibiotic, were not found to be different once cephalexin was added to media. A greater 
number of new compounds were found to be different with the addition of cephalexin to the 
media, and unlike previously, the majority of these compounds were more likely to be present 
in sensitive isolates and absent in resistant ones. The only exception was dimethyl trisulphide, 
which was more likely to be present in resistant isolates. Of the compounds significantly 
associated with sensitive isolates, there were three medium-chain aldehydes (octanal, 
undecanal and dodecanal) and three volatile sulphur compounds (dimethyl sulphide, dimethyl 
disulphide and methyl ethyl sulphide). A proposed explanation is that sensitive bacterial cell 
walls lysed, and resistant cells did not. Lysis causes cell contents to be released into the 
media, thus increasing the differences between sensitive cells and their resistant counterparts. 
Cephalexin is a cephalosporin class beta-lactam, whose mode of action is the prevention of 
the formation of the bacterial cell wall, leaving sensitive cells vulnerable to lysis without the 
protection of an intact cell wall. As a note, trichloromethane described in table 5, was once 
considered to be man-made however, it is now known that it can also be biosynthesised by 
some microorganisms [27].  
  
Chi-square analysis found 22 compounds whose presence/absence differed significantly 
between ciprofloxacin sensitive and ciprofloxacin resistant bacterial isolates at p ≤0.05, 
without ciprofloxacin added to the media, shown in table 6. With the addition of ciprofloxacin 
to the media, 5 compounds were identified whose presence absence differed under the same 
parameters, shown in table 7.  
 
Table 6. Compounds which are different in ciprofloxacin sensitive and resistant E. coli and K. 
pneumoniae isolates, and the percentage occurrence of compounds in samples 
 













Carbon dioxide 2.87 40 0.0 Dimethyl trisulphide 16.32 13.3 47.1 
Acetaldehyde 3.97 33.3 0.0 - - - - 
Acetone 6.39 40 0.0 - - - - 
2-Butanone 9.41 26.7 0.0 - - - - 
Benzene 10.72 26.7 0.0 - - - - 
Cyclobutene-2-
propenylidene  
12.98 33.3 0.0 - - - - 
Butanoic acid 13.92 33.3 5.9 - - - - 
p-Xylene 15.05 33.3 0.0 - - - - 
Octanal 16.45 33.3 0.0 - - - - 
Diethylene glycol ethyl 
ether 
16.58 33.3 0.0 - - - - 
2-Ethyl-1-hexanol 16.78 33.3 0.0 - - - - 
Heptanoic acid 17.47 26.7 5.9 - - - - 
Acetophenone 17.78 33.3 0.0 - - - - 
Nonanoic acid 20.12 26.7 0.0 - - - - 
Undecanal 20.62 33.3 0.0 - - - - 
2-Undecenal 22.03 26.7 0.0 - - - - 
Indole 22.33 33.3 5.9 - - - - 
Dodecanal 22.41 26.7 0.0 - - - - 
Tetradecanal 22.57 26.7 0.0 - - - - 
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Hexadecane 23.51 33.3 0.0 - - - - 
1-Dodecanol 24.04 26.7 0.0 - - - - 
S = sensitive and R = resistant. RT = retention time.  
 
Table 7. Compounds which are different in ciprofloxacin sensitive and resistant E. coli and K. 
pneumoniae isolates with antibiotic added to culture media, and the percentage occurrence 
of compounds in samples 
 
More likely in Ciprofloxacin S (+AB) 
Compound RT (mins) In % of S In % of R 
Carbon dioxide 2.81 42.9 0.0 
Methyl ethyl sulphide 9.54 42.9 0.0 
Dimethyl disulphide 12.58 42.9 0.0 
Undecanal 20.48 42.9 0.0 
Dodecanal 22.41 42.9 0.0 
S = sensitive and R = resistant. RT = retention time. AB = antibiotic (ciprofloxacin).  
 
When ciprofloxacin was added to the media, many of the compounds identified previously as 
being different between sensitive and resistant isolates were no longer found to be significantly 
different. Ciprofloxacin is a broad-spectrum fluoroquinolone class antibiotic, with a different 
mechanism of action to cephalexin. Rather than threatening the integrity of the cell wall, 
ciprofloxacin prevents DNA synthesis by inhibiting DNA gyrase (prevents uncoiling of DNA) 
and topoisomerase IV (interferes with cell division). This mechanism would not necessarily 
cause cells to lyse.  
 
Dodecanal and carbon dioxide were more likely to be found in sensitive isolates, both with and 
without the addition of antibiotics. However, methyl ethyl sulphide, dimethyl disulphide, and 
undecanal were only found to be different between sensitive and resistant isolates when 
antibiotic was added.  
 
Statistical analysis taking into account the differences in peak areas i.e. the abundance of 
each compound, was performed using independent T-tests and Mann-Whitney-Wilcoxon 
tests. However, the results of these tests did not qualitatively differ from the results of the chi-
square tests and for this reason are not reported.  
 
From a starting culture, TD-GC-MS offers rapid profiling of bacteria (2 minutes for tube loading 
plus 26 minutes for GC-MS analysis), which is far quicker than traditional microbiological 
methods of susceptibility testing (around 24 hours). Once biomarkers have been 
unambiguously assigned, the analytical method would be refined and would be expected to 
be much more rapidly undertaken.  
 
Additional work with a greater number of isolates, and the addition of standard compounds, 
may enable the development of diagnostic algorithms to predict species and susceptibility 
using the presence/absence of particular compounds of interest. The creation of diagnostic 
algorithms are possible using statistical modelling and/or pattern recognition software. This 
methodology could also be applied to other clinically relevant bacteria.  
 
There is potential to use volatile profiles for faster and lower cost analysis using a shorter 
column and different chromatographic conditions and detection systems. Once compounds of 
interest have been identified and diagnostic algorithms created using gold-standard GC-MS, 
gas sensors specific to these compounds could be put together in an array. This type of sensor 
system offers online rapid analysis, as well as being relatively inexpensive, portable and user-
friendly. Gould et al. (2017) recently reported use of heated metal oxide semiconductor 
sensors to detect VCs; unlike mass spectrometry, this type of sensor has negligible responses 
to siloxanes, and thus offers a solution to siloxane contamination adversely affecting the VC 
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profile [28]. For UTIs, the high sensitivity of this type of sensor array may remove the need to 
culture bacteria prior to analysis, allowing direct analysis of urine for both species identification 
and susceptibility testing.  
 
4. Conclusions  
 
Significant differences in volatile profiles were found between cephalexin resistant and 
sensitive isolates of E. coli and K. pneumoniae, and between ciprofloxacin sensitive and 
resistant isolates of the same bacterial species. Differences were found with and without the 
addition of antibiotic. Bacteria were rapidly analysed by TD-GC-MS, in less than 30 minutes 
from a starting culture, as opposed to 24 hours for traditional susceptibility tests. This 
technology if developed further could be used as a diagnostic tool to reduce inappropriate 
prescribing of antibiotics.  
 
Significant differences in volatile profiles were also found between three UTI-causing bacterial 
species. Another potential application of this technology could be rapid differential diagnosis 
between UTI-causing bacteria.  
 
Further work is required to validate these findings on a larger data set particularly using 
clinically obtained urine samples. This will allow robust statistical models to be built and tested 
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